The amount of revenue to be received upon the achievement of specified net sales thresholds for all licensed products.

No definition available.

Name:	glyc_AchievementOfSpecifiedNetSalesThresholdsForAllLicensedProducts
Namespace Prefix:	glyc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	glyc_ArrangementsAndNonarrangementTransactionsLineItems
Namespace Prefix:	glyc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of development and regulatory specific approval milestones based on achievement of certain clinical and regulatory events.

+ References

No definition available.

+ Details

Name:	glyc_DevelopmentAndRegulatoryApprovalMilestonesClinicalAndRegulatoryEvents
Namespace Prefix:	glyc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The milestone revenue recognized.

+ References

No definition available.

+ Details

Name:	glyc_MilestoneRevenueRecognized
Namespace Prefix:	glyc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of revenue from the sale of clinical supplies.

+ References

No definition available.

+ Details

Name:	glyc_RevenueReceivedFromSaleOfClinicalSupplies
Namespace Prefix:	glyc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The entitled royalty payments to be received based on a tiered percentage of annual net sales.

+ References

No definition available.

+ Details

Name:	glyc_TieredPercentageOfAnnualNetSales
Namespace Prefix:	glyc_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of up-front payment received under terms of the agreement.

+ References

No definition available.

+ Details

Name:	glyc_UpFrontPaymentReceived
Namespace Prefix:	glyc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=glyc_ApollomicMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Research and License Agreements (Details) - Apollomics, Inc. - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Dec. 31, 2021
Research and License Agreements
Revenue from sale of clinical supplies			$ 1.1
Up-front payment received		$ 9.0
Milestone revenue recognized based on achievement of certain clinical and regulatory events	$ 1.0
Maximum
Research and License Agreements
Milestones based on achievement of certain clinical and regulatory events		75.0
Milestone payment upon achievement of specified net sales thresholds for all licensed products		$ 105.0
Tiered percentage of annual net sales		15.00%